ProtAffin AG appoints Dr. Simon Moroney to Supervisory Board
Dr. Moroney is Chief Executive Officer of MorphoSys AG in Martinsried/Munich, Germany. Prior to co-founding MorphoSys in 1992, Dr. Moroney held positions at the University of Cambridge, UK, at the University of British Columbia, Canada, and in the Chemistry Department of the ETH in Zurich, Switzerland. Subsequently he was an Associate in the Harvard Medical School, Boston, USA and an employee of ImmunoGen Inc., where he worked on the development of antibody-based cancer drugs. Since 1992, Dr. Moroney has led MorphoSys to its position as one of the leading biologics companies in Europe and the USA, with a broad-ranging strategic alliance with Novartis AG. In 2002, Dr. Moroney was awarded the Bundesverdienstkreuz am Bande (Cross of the Order of Merit of the Federal Republic of Germany) for his services to the biotechnology industry.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.